Optimal molecular crowding accelerates group II intron folding and maximizes catalysis
Unlike in vivo conditions, group II intron ribozymes are known to require high magnesium(II) concentrations ([Mg2+]) and high temperatures (42 °C) for folding and catalysis in vitro. A possible explanation for this difference is the highly crowded cellular environment, which can be mimicked in vitro...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 115; no. 47; pp. 11917 - 11922 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
20.11.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Unlike in vivo conditions, group II intron ribozymes are known to require high magnesium(II) concentrations ([Mg2+]) and high temperatures (42 °C) for folding and catalysis in vitro. A possible explanation for this difference is the highly crowded cellular environment, which can be mimicked in vitro by macromolecular crowding agents. Here, we combined bulk activity assays and single-molecule Förster Resonance Energy Transfer (smFRET) to study the influence of polyethylene glycol (PEG) on catalysis and folding of the ribozyme. Our activity studies reveal that PEG reduces the [Mg2+] required, and we found an “optimum” [PEG] that yields maximum activity. smFRET experiments show that the most compact state population, the putative active state, increases with increasing [PEG]. Dynamic transitions between folded states also increase. Therefore, this study shows that optimal molecular crowding concentrations help the ribozyme not only to reach the native fold but also to increase its in vitro activity to approach that in physiological conditions. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 1B.P.P., E.F., and R.B. contributed equally to this work. Edited by Joseph D. Puglisi, Stanford University School of Medicine, Stanford, CA, and approved October 5, 2018 (received for review May 21, 2018) Author contributions: B.P.P., E.F., R.B., R.K.O.S., and D.S.R. designed research; B.P.P., E.F., and R.B. performed research; B.P.P., E.F., R.B., R.K.O.S., and D.S.R. analyzed data; and B.P.P., E.F., R.B., R.K.O.S., and D.S.R. wrote the paper. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1806685115 |